Product type: Pharma

Turku Science Park LevelUp

Incubation service in Turku, Finland, that has been running already for six years. Participating startups should have graduated from an acceleration program or be otherwise ready to sell their product to early customers.

They offer a network of mentors and industry contacts in addition to a working space for 12 months. The program is completely free of charge.

Their program for the autumn 2020 is being designed and its detailed information is expected to be released in the summer. You can ask more from marko.puhtila@turkubusinessregion.com.

Turku Science Park BusinessUp

Acceleration program in Turku, Finland, that has been running already for four years. Participating startups can be of any type and do not need to have any working prototype or proof-of-concept yet, but should be ready to start turning their idea into reality.

They offer a mentoring program for 10 weeks. The program is completely free of charge.

Their autumn 2020 applications are open 1.6.-1.9.2020. You can ask more from johanna.puhtila@turkubusinessregion.com.

Boost Turku Startup Journey

Startup Journey by Boost Turku is a free early-stage acceleration program: no charges, no equity taken. Next batch is digital. Earlier ones have been onsite in Turku, Finland, and upcoming ones may be physical with digital participation possibly an option. Most selected teams will be from Turku region in Finland as the organization’s mission is to support the local ecosystem.

They select teams (not solo founders) that have done at least some work already on the idea, e.g. competitor identification and evaluation. Teams have to be able to clearly state their solution that has some competitive advantage.

The goal of the program is to help you develop your concept and get you towards first revenue.

Their community page with mentors etc. can be found at facebook.com/BoostStartupJourney.

Health Incubator Helsinki

Rolling applications are also reviewed all the time and the program’s open network can help in many ways even outside the official program.

For the full program, spring application period is until 30.4.2020. Autumn application period will be opened after summer.

The program is geared especially for research-based teams and founders to develop their business in the health sector. Focusing on very early stage, from first proof-of-concept or traction onwards.

Turing Studio

Fundraising, branding, design and business development consulting. Helping clients with development projects around the globe.

Does not organize clinical trials, but they do user research and interviews and help with all business areas.

GrayBella Capital

GrayBella Capital is a pan-European venture capital fund investing in healthcare and complex technology fast growth companies. They invest €2-7M in trenches and welcome other investors on board.

Their goal is to help companies scale internationally while keeping core operations locally in their primary market.

They have a preference for B2B. Their especial focus is on bioinformatics, genomics and other areas where health meets IT. Clinical trials are out of their scope.

Earth Capital

Doing sustainability and impact investing: mobility, food and agriculture, energy (renewable, efficiency, storage), water, waste etc. Looking for indications of repeat demand.

Looking for defensible market positions. Technology is not necessary, if the position of the company is otherwise strategically defensible.

Investing globally with a focus on Europe. Also investing actively in Africa and Asia.

Focus on B2B across all their funds.

Prefer to lead or co-invest. Prefer to take a board seat.

SijoittajaPRO

Open family office: network of family offices and angels. They do financial investments and prefer co-investing alongside existing investors.

They invest in solutions that customers like and have demand for. Solution doesn’t need to be technological, but it can be if lead investor has done technological due diligence.

Also offer loans for companies with any business types, including B2C.

They’ve invested €41M in four years.

Innovestor

Innovestor offers co-investing (syndicate forming) as a service. They also do solo investments.

Prefer B2B, but open to any business types. Drug development is not currently interesting for them, but digital health and medical technology is.

Funding applications can be filled at https://innovestorgroup.com/growth-companies/#applyfunding.

SpeedUp Venture Capital

SpeedUp invests in companies that have a connection with Poland. This can come in many forms within 5 years after the investment, for example R&D or sales.

Most of their investments are in B2B, B2B2C and SaaS companies. B2G is possible in cases with strong indications of ability to sell and scale.

It’s common for them to be the only investor in the round, but they’ll be happy to lead or co-invest as well.

SpeedUp has two funds with different investment criteria.

Larger fund

Ticket size €600k – 1M, sweet spot 750k, maximum total allocation per company 5M.

Product type: Any tech except pharma, very rarely also Marketplaces (connection with e.g. energy, IoT, industry, smart manufacturing, cleantech)

Revenue: €100k/y or more.

Product readiness level: Product or Scaling

Valuation: Max €10M

Smaller fund

Ticket size €200k-250k, sweet spot 250k, maximum total allocation per company 250k (no follow-on).

Product type: Any tech that has an R&D component. No marketplaces. Pharma is possible.

Revenue: None or any.

Product stage: Proof of Concept, Prototype or Product.

Valuation: Max €4M

The company’s requirements for a connection with Poland are more strict.

General information

The information below is generated automatically from the investor’s overall information in our database, which doesn’t separate between different funds of the same investor.